/Investor DB

Westlake Village BioPartners — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Akamis Bioakamisbio.comin𝕏Jan 2023

Akamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life.

BiotechDigital HealthHealthtechMedical DevicesCambridge, MA, US

Howard Davis, PhD(Chief Executive Officer)

Co-investorsARCH Venture PartnersSR One Capital ManagementIP GroupLundbeckfonden Ventures

Kate Therapeuticskatetherapeutics.comin𝕏Jun 2023

A patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.

BiotechSan Diego, US

Kevin Forrest, Ph.D.(Executive Officer, Director)

BoardClare Ozawa, Ph.D.(Director)Beth Seidenberg, M.D.(Director)

Co-investorsOUP (Osage University Partners)Kleiner PerkinsVersant Ventures

Meanwhile Bitcoin backed insurance Moneymeanwhile.bmin𝕏Seed · Jun 2023 · $19M

Meanwhile is a licensed Bitcoin-denominated life insurance company whose policies collect premiums and pay death benefits in BTC, with premiums that grow at a guaranteed rate in Bitcoin terms and the option to take Bitcoin loans against policy value.

Crypto & Web3FintechInsurTechHamilton, BM

Tia Beckmann(Chief Financial Officer)inMax Gasner(Founder)Zac Townsend(Founder)in

Co-investorsFramework VenturesFulgur VenturesGradient VenturesSam Altman6th Man VenturesHaun Ventures+9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.